At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
03692 HANSOH PHARMA
Not Yet Opened 01-09 16:08:42
16.480
+0.260
+1.60%
High16.760
Low16.320
Vol4.62M
Open16.380
D1 Closing16.220
Amplitude2.71%
Mkt Cap97.82B
Tradable Cap97.82B
Total Shares5.94B
T/O76.30M
T/O Rate0.08%
Tradable Shares5.94B
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
BRIEF-Hansoh Pharmaceutical Says HS-20093 Received FDA Breakthrough Therapy Designation Refractory Osteosarcoma
Merck Will Gain Exclusive Global License to Develop, Manufacture & Commercialize Chinese Drugmaker Hansoh Pharmaceutical Group's Hs-10535 -Bloomberg News
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED is a China-based investment holding company principally involved in the the research and development, production and sale of pharmaceutical products. The Company’s main products include Oulanning, Ameining, Pulaile, Zefei, Xinwei, Xinmei, Zetan, Mailingda, Hengjie, Hengsen, Fulaidi and Ruibote, among others. The Company’s products are mainly used for central nervous system disease, oncology, anti-infection, diabetes, digestive tract and cardiovascular treatment. The Company distributes its products in domestic market.